What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Immune system
His primary areas of study are Immunology, Autoimmune disease, Internal medicine, Rheumatoid arthritis and Molecular biology.
His study in Immunology focuses on T cell, Antibody, Arthritis, Lupus erythematosus and T lymphocyte.
His work carried out in the field of Autoimmune disease brings together such families of science as Receptor, Autoantibody, Autoimmunity and Cellular immunity.
MHC class I is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.
His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Promoter, Blisibimod and Immunopathology.
His Molecular biology research is multidisciplinary, incorporating elements of MAPK/ERK pathway, Cellular differentiation, Smad2 Protein and Synovial membrane.
His most cited work include:
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (1096 citations)
- A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details (525 citations)
- Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. (300 citations)
What are the main themes of his work throughout his whole career to date?
Takayuki Sumida focuses on Immunology, Internal medicine, Rheumatoid arthritis, Arthritis and Molecular biology.
His Immunology study focuses mostly on Antibody, Autoantibody, Autoimmune disease, T cell and Antigen.
The various areas that Takayuki Sumida examines in his Internal medicine study include Gastroenterology, Endocrinology and Surgery.
His study explores the link between Rheumatoid arthritis and topics such as Infliximab that cross with problems in Etanercept.
His studies deal with areas such as Tumor necrosis factor alpha and Interleukin 6, Cytokine as well as Arthritis.
His research integrates issues of Gene expression, Gene, Synovial membrane, Apoptosis and Receptor in his study of Molecular biology.
He most often published in these fields:
- Immunology (50.56%)
- Internal medicine (29.80%)
- Rheumatoid arthritis (23.70%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (50.56%)
- Internal medicine (29.80%)
- Rheumatoid arthritis (23.70%)
In recent papers he was focusing on the following fields of study:
Takayuki Sumida spends much of his time researching Immunology, Internal medicine, Rheumatoid arthritis, Antibody and Arthritis.
His work deals with themes such as Linkage disequilibrium and Allele, which intersect with Immunology.
In general Internal medicine study, his work on Rheumatology and Tocilizumab often relates to the realm of In patient, thereby connecting several areas of interest.
His Rheumatoid arthritis research integrates issues from Prospective cohort study and Disease.
His studies in Antibody integrate themes in fields like Molecular biology, Citrullination, Citrulline and Antigen.
Takayuki Sumida works mostly in the field of Arthritis, limiting it down to concerns involving Tumor necrosis factor alpha and, occasionally, Interleukin 6.
Between 2015 and 2021, his most popular works were:
- High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry (133 citations)
- Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI) (118 citations)
- Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His main research concerns Internal medicine, Immunology, Rheumatoid arthritis, Rheumatology and Arthritis.
Takayuki Sumida combines subjects such as Gastroenterology, Physical therapy and Surgery with his study of Internal medicine.
Autoantibody is the focus of his Immunology research.
His Rheumatoid arthritis study combines topics in areas such as Prospective cohort study, Antibody, Chemotaxis and Abatacept.
The Rheumatology study combines topics in areas such as Polymyositis, Dermatomyositis, Systemic lupus erythematosus, Rituximab and Lupus nephritis.
Takayuki Sumida interconnects Inflammation, Interleukin 6 and Tumor necrosis factor alpha in the investigation of issues within Arthritis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
